Managing antithrombotic therapy in immune thrombocytopenia: development of the TH2 risk assessment score
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 20, 2018
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1114 Paediatrics and Reproductive Medicine (FoR)
- Aged (MeSH)
- Aged, 80 and over (MeSH)
- Female (MeSH)
- Fibrinolytic Agents (MeSH)
- Humans (MeSH)
- Immunology (Science Metrix)
- Longitudinal Studies (MeSH)
- Male (MeSH)
- Middle Aged (MeSH)
- Purpura, Thrombocytopenic, Idiopathic (MeSH)
- Registries (MeSH)
- Risk Assessment (MeSH)
published in
- Blood Journal